Posted 11th December 2019 by Joshua Sewell
David Butler is Associate Professor at the University of Tennessee, USA. His research focuses on soil-plant and soil-plant-microbe relationships in horticultural cropping systems. In particular, David is interested in understanding non-chemical and biological soil disinfestation techniques and their mechanisms of pathogen control, the effect of alternative soil disinfestation practices on soil fertility and crop nutrition, and the how the nutrient cycle dynamics of annual and perennial cover crops can alter to improve crop nutrition.
Posted 9th December 2019 by Joshua Sewell
Some of the claims made about Probiotics can be hard to believe, and often even harder to reliably prove. However, the science surrounding the development of these products is exciting, and some of the more extraordinary claims can be quantified.
Here a few examples from some of the presentations at the Microbiome & Prebiotics Series: USA:
Presentation Slides from the 4th Partnerships in Biocontrol, Biostimulants & Microbiome Congress: USA
Posted 4th December 2019 by Joshua Sewell
At the recent 4th Partnerships in Biocontrol, Biostimulants & Microbiome Congress: USA we heard a number of interesting presentations on how plant and soil microbiome research is identifying microbes to enhance crop productivity and disease resistance.
Thanks to some of our speakers, we have made the following slides discussing the current regulatory landscape from Sarah Caffery, Keith Matthews, and Terry Stone available to view.
Posted 2nd December 2019 by Joshua Sewell
I am extremely sceptical of all claims about probiotics. For the last 10 years of running Probiotics.org, companies have been sending me questionable products with extraordinarily impossible to believe claims.
But, after Global Engage’s 4th Probiotic & Prebiotics Congress, here’s what I strongly believe:
Posted 29th November 2019 by Joshua Sewell
The recent 7th Plant Genomics Congress: USA provided a fantastic opportunity to discover how novel gene-editing technologies, CRISPR and other ‘omics’ technologies are being applied to research and product development. We have made the following slides from Jerry Feitelson, Lynne Reuber, Greg Bryan and Chloe Pavely available to view.
Posted 27th November 2019 by Liv Sewell
Transplantation is now a successful therapy for end-stage renal disease (ESRD). The first successful kidney transplantation happened in Boston in 1954 and the procedure is now routine clinical practice in more than 80 countries worldwide.
Ishita Moghe and Kim Solez outline some of the major strides taken in kidney pathology and transplantation through the use of scRNA-seq and Artificial Intelligence (AI).
Posted 26th November 2019 by Joshua Sewell
The 4th Medicinal Chemistry & Protein Degradation Summit provided two days of fascinating topics and case studies about AI-assisted lead optimisation, DNA encoded libraries and the use of data and informatics in drug-discovery. We have made the following presentation slides available from Greg Makara, Paul Colbon and Yugal Sharma.
Posted 22nd November 2019 by Liv Sewell
Natural resistance to our methods to control pests and weeds is a brand new phenomenon, historically speaking. It only evolved as mankind started to use chemical, and later biotechnological means to control nature. Genetic modification may not be the answer to resistance. Attempts to control pests and weeds by growing GM plants run into the same problem as the application of chemical agents. But still, nature may provide some answers.